ANTIBACTERIALS >CEPHALOSPORINS > EXTACEF® - i Injection

For the use of a Registered Medical Practitioner, a Hospital or a Laboratory only.
COMPOSITION
EXTACEF- i 250 mg. INJ.
Each Vial Contains:
Sterile Ceftriaxone Sodium IP Equivalent to Anhydrous Ceftriaxone 250 mg
 
EXTACEF -i 500 mg. INJ.
Each Vial Contains:
Sterile Ceftriaxone Sodium IP Equivalent to Anhydrous Ceftriaxone 500 mg
 
EXTACEF- i 1G. INJ.
Each Vial Contains:
Sterile Ceftriaxone Sodium IP Equivalent to Anhydrous Ceftriaxone 1000 mg
 
INDICATIONS
EXTACEF-i is indicated for treatment of lower respiratory tract infections, skin and skin structure infections, complicated and uncomplicated urinary tract infections, uncomplicated gonorrhoea, pelvic inflammatory disease, bacterial septicemia, bone and joint infections and in surgical prophylaxis.
DOSAGE AND ADMINISTRATION
Parenteral (IM/IV): The usual adult dose is 1-2 g.o.d./b.d. Total daily dose should not exceed 4 g.In Infants and Young children : 20-80 mg / kg / day.
Premature babies/Neonates : Less than 50 mg / kg /day. Ceftriaxone regimen should be continued for 72 hours after fever abates or after evidence of bacterial eradication. In Gonorrhoea: A single intramuscular dose of 250 mg is recommended.
Ceftriaxone for intramuscular injection should be given in 1% lignocaine and administered by a deep intragluteal injection to minimize pain).
For the treatment of serious infections in children other than meningitis the recommended total daily dose is 50-75 mg / kg body wt. (not to exceed 2 g) given in 2 divided doses. For preoperative use (surgical prophlyxis) a single dose given ½ to 2 hours before surgery is recommended.
For Strep. pyogenes infections 10 day regimen is required. No dose adjustment is required under renal or hepatic dysfunction but serum levels should be monitored in patients with other severe renal impairment (eg. Dialysis patients) or in patients suffering from both renal and hepatic malfunction

HOW SUPPLIED
Twin pack: Vial & srterile water for injection as a diluent.